105
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      BAX Activation is Initiated at a Novel Interaction Site

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BAX is a pro-apoptotic protein of the BCL-2 family stationed in the cytosol until activated by a diversity of stress stimuli to induce cell death. Anti-apoptotic proteins such as BCL-2 counteract BAX-mediated cell death. Although an interaction site that confers survival functionality has been defined for anti-apoptotic proteins, an activation site has not been identified for BAX, rendering its explicit trigger mechanism unknown. We previously developed Stabilized Alpha- Helix of BCL-2 domains (SAHBs) that directly initiate BAX-mediated mitochondrial apoptosis. Here we demonstrate by NMR analysis that BIM SAHB binds BAX at an interaction site that is distinct from the canonical binding groove characterized for anti-apoptotic proteins. The specificity of the BIM SAHB-BAX interaction is highlighted by point mutagenesis that abrogates functional activity, confirming that BAX activation is initiated at this novel structural location. Thus, we have now defined a BAX interaction site for direct activation, establishing a new target for therapeutic modulation of apoptosis.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: found
          • Article: not found

          Cell death: critical control points.

          Programmed cell death is a distinct genetic and biochemical pathway essential to metazoans. An intact death pathway is required for successful embryonic development and the maintenance of normal tissue homeostasis. Apoptosis has proven to be tightly interwoven with other essential cell pathways. The identification of critical control points in the cell death pathway has yielded fundamental insights for basic biology, as well as provided rational targets for new therapeutics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

            We report here the purification of the third protein factor, Apaf-3, that participates in caspase-3 activation in vitro. Apaf-3 was identified as a member of the caspase family, caspase-9. Caspase-9 and Apaf-1 bind to each other via their respective NH2-terminal CED-3 homologous domains in the presence of cytochrome c and dATP, an event that leads to caspase-9 activation. Activated caspase-9 in turn cleaves and activates caspase-3. Depletion of caspase-9 from S-100 extracts diminished caspase-3 activation. Mutation of the active site of caspase-9 attenuated the activation of caspase-3 and cellular apoptotic response in vivo, indicating that caspase-9 is the most upstream member of the apoptotic protease cascade that is triggered by cytochrome c and dATP.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

              Bcl-2 protein is able to repress a number of apoptotic death programs. To investigate the mechanism of Bcl-2's effect, we examined whether Bcl-2 interacted with other proteins. We identified an associated 21 kd protein partner, Bax, that has extensive amino acid homology with Bcl-2, focused within highly conserved domains I and II. Bax is encoded by six exons and demonstrates a complex pattern of alternative RNA splicing that predicts a 21 kd membrane (alpha) and two forms of cytosolic protein (beta and gamma). Bax homodimerizes and forms heterodimers with Bcl-2 in vivo. Overexpressed Bax accelerates apoptotic death induced by cytokine deprivation in an IL-3-dependent cell line. Overexpressed Bax also counters the death repressor activity of Bcl-2. These data suggest a model in which the ratio of Bcl-2 to Bax determines survival or death following an apoptotic stimulus.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                0028-0836
                1476-4687
                5 September 2008
                23 October 2008
                23 April 2009
                : 455
                : 7216
                : 1076-1081
                Affiliations
                [1 ] Departments of Pediatric Oncology and the Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, the Division of Hematology/Oncology, Children’s Hospital Boston, and the Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA
                [2 ] Laboratory of Molecular Biophysics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 USA
                [3 ] Departments of Medicine and Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110 USA
                Author notes
                Author Information Structural coordinates have been submitted to the PDB database under accession code 2K7W. Reprints and permission information is available at www.nature.com/reprints. The authors declare competing financial interests: L.D.W. is a scientific advisory board member and consultant for Aileron Therapeutics, Inc. Correspondence and requests for materials should be addressed to N.T. ( tjandran@ 123456nhlbi.nih.gov ) or L.D.W. ( loren_walensky@ 123456dfci.harvard.edu ).
                [*]

                These authors contributed equally to this work

                [†]

                To whom correspondence should be addressed: loren_walensky@dfci.harvard.edu and tjandran@nhlbi.nih.gov

                Author Contributions G.H.B. and L.D.W. designed, synthesized, and characterized the SAHBs for structural and biological studies. M.S. and N.T. performed the NMR analysis of BAX and BIM SAHB, and E.G. and L.D.W. conducted the PRE-NMR analysis of BAX using MTSL-derivatized SAHBs and performed the structure calculations. E.G., M.L.D., and K.P. executed the in vitro BAX activation studies. H.-C.T., H.K., and E.H.-Y.C. generated the BAX-reconstituted DKO MEFs and analyzed their response to staurosporine, whereas S.G.K. examined the cellular response to BIM SAHB treatment.

                Article
                NIHMS68617
                10.1038/nature07396
                2597110
                18948948
                ea9cbecc-8b05-4782-baed-ec0a79076ed1
                History
                Funding
                Funded by: National Cancer Institute : NCI
                Funded by: National Heart, Lung, and Blood Institute : NHLBI
                Award ID: R01 CA125562-02 ||CA
                Funded by: National Cancer Institute : NCI
                Funded by: National Heart, Lung, and Blood Institute : NHLBI
                Award ID: K99 HL095929-02 ||HL
                Funded by: National Cancer Institute : NCI
                Funded by: National Heart, Lung, and Blood Institute : NHLBI
                Award ID: K99 HL095929-01A1 ||HL
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article